tiprankstipranks
Trending News
More News >
Arecor Therapeutics PLC (GB:AREC)
:AREC

Arecor Therapeutics PLC (AREC) Price & Analysis

Compare
3 Followers

AREC Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

5.27%94.73%
Mutual Funds
― Other Institutional Investors
94.73% Public Companies and
Individual Investors

AREC FAQ

What was Arecor Therapeutics PLC’s price range in the past 12 months?
Arecor Therapeutics PLC lowest share price was 0.35p and its highest was 1.15p in the past 12 months.
    What is Arecor Therapeutics PLC’s market cap?
    Arecor Therapeutics PLC’s market cap is £16.99M.
      When is Arecor Therapeutics PLC’s upcoming earnings report date?
      Arecor Therapeutics PLC’s upcoming earnings report date is Sep 18, 2025 which is in 71 days.
        How were Arecor Therapeutics PLC’s earnings last quarter?
        Arecor Therapeutics PLC released its earnings results on Apr 22, 2025. The company reported -0.155p earnings per share for the quarter, missing the consensus estimate of N/A by -0.155p.
          Is Arecor Therapeutics PLC overvalued?
          According to Wall Street analysts Arecor Therapeutics PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Arecor Therapeutics PLC pay dividends?
            Arecor Therapeutics PLC does not currently pay dividends.
            What is Arecor Therapeutics PLC’s EPS estimate?
            Arecor Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Arecor Therapeutics PLC have?
            Arecor Therapeutics PLC has 37,756,600 shares outstanding.
              What happened to Arecor Therapeutics PLC’s price movement after its last earnings report?
              Arecor Therapeutics PLC reported an EPS of -0.155p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Arecor Therapeutics PLC?
                Currently, no hedge funds are holding shares in GB:AREC

                Company Description

                Arecor Therapeutics PLC

                Arecor Therapeutics PLC (AREC) is a biopharmaceutical company specializing in the development and commercialization of innovative medicines aimed at improving patient care and outcomes. The company operates within the pharmaceutical and biotechnology sectors, focusing on leveraging its proprietary formulation technology platform, Arestat™, to enhance the efficacy, safety, and stability of existing therapeutic products. Arecor's core offerings include proprietary products, partnered specialty medicines, and formulations for medicines in partnerships with leading pharmaceutical and biotechnology companies.
                Similar Stocks
                Company
                Price & Change
                Follow
                Tissue Regenix
                Sareum Holdings
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis